ICU Medical (ICUI) FY2011 results: revenue $302 million, up 6.8% on the year
ICU Medical Inc. (ICUI) reported revenue of $302 million for fiscal 2011, the year ended 31 December 2011, up 6.8% on the year before. Net income was $45 million, up 49.3%, and diluted earnings per share $3.15. The figures are the company's own, from the 10-K it filed with the SEC on 23 March 2012.
Revenue
$302 million
+6.8% on the year
FY2007FY2011
Operating margin
21.6%
16.8% a year earlier
FY2007FY2011
Net income
$45 million
+49.3% on the year
FY2007FY2011
Diluted EPS
$3.15
+41.3% on the year
FY2007FY2011
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2011
FY2010
FY2009
On the year
Last 8 years
Revenue
302
283
229
+6.8%
Cost of revenue
160
154
123
+3.8%
Gross profit
142
129
106
+10.4%
Gross margin
47.1%
45.6%
46.4%
Research and development
8.6
4.7
2.6
+83.6%
Selling, general and administrative
85.3
76.6
68.2
+11.3%
Operating income
65.2
47.7
35.4
+36.9%
Operating margin
21.6%
16.8%
15.5%
Pre-tax income
66.4
47.8
36.6
+39.0%
Income tax
21.8
17.9
11.6
+21.8%
Effective tax rate
32.7%
37.4%
31.8%
Net income
44.7
29.9
25.0
+49.3%
Net margin
14.8%
10.6%
10.9%
Diluted EPS
$3.15
$2.23
$1.67
+41.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2011
FY2010
FY2009
On the year
Last 8 years
Operating cash flow
64.5
33.1
51.1
+94.9%
Capital expenditure
15.8
23.2
16.7
-31.7%
Free cash flow
48.7
9.9
34.4
+390.4%
Free cash flow margin
16.1%
3.5%
15.0%
Cash from investing
-45.7
19.6
-37.8
Cash from financing
2.1
-22.9
-17.7
Depreciation and amortisation
18.3
17.3
15.7
+5.5%
Share-based compensation
4.0
3.5
2.7
+15.7%
Buybacks
12.0
28.6
20.4
-58.3%
Diluted shares, weighted
14m
14m
15m
+2.2%
Shares outstanding at period end
14m
14m
14m
+1.6%
Balance sheet
$ million
FY2011
FY2010
FY2009
On the year
Last 8 years
Shareholders' equity
321
272
263
+18.0%
Non-controlling interest
n/a
n/a
1.6
Debt
0.0
0.0
n/a
Other liabilities
40.5
37.9
44.1
+6.8%
Total liabilities and equity
361
310
309
+16.6%
Fixed assets
85.9
83.5
77.4
+2.9%
Goodwill
1.5
1.5
1.5
0.0%
Intangible assets
11.4
14.8
16.8
-22.9%
Investments
60.4
14.5
56.9
+316.3%
Cash and equivalents
99.6
78.8
51.2
+26.3%
Receivables
43.6
50.9
47.8
-14.5%
Inventory
40.4
44.1
41.3
-8.2%
Other assets
18.3
21.5
16.2
-14.7%
Total assets
361
310
309
+16.6%
10-K for the year ended 31 December 2011, filed 23 March 2012: the filing.